Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rockwell Medical (RMTI) Return on Equity (2016 - 2025)

Rockwell Medical's Return on Equity history spans 15 years, with the latest figure at 0.15% for Q4 2025.

  • For Q4 2025, Return on Equity fell 13.0% year-over-year to 0.15%; the TTM value through Dec 2025 reached 0.15%, down 13.0%, while the annual FY2025 figure was 0.16%, 14.0% down from the prior year.
  • Return on Equity reached 0.15% in Q4 2025 per RMTI's latest filing, up from 0.17% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 28.25% in Q1 2022 to a low of 4.79% in Q4 2021.
  • Average Return on Equity over 5 years is 0.41%, with a median of 0.51% recorded in 2023.
  • Peak YoY movement for Return on Equity: soared 2923bps in 2022, then crashed -2924bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 4.79% in 2021, then surged by 74bps to 1.24% in 2022, then skyrocketed by 67bps to 0.41% in 2023, then skyrocketed by 96bps to 0.02% in 2024, then plummeted by -740bps to 0.15% in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Return on Equity are 0.15% (Q4 2025), 0.17% (Q3 2025), and 0.07% (Q2 2025).